-
5-EdU: From DNA Synthesis to Translational Insight
2026-09-11
A mechanistic and strategic guide to using 5-Ethynyl-2'-deoxyuridine (5-EdU) for S phase DNA synthesis detection, developmental birthdating, cell proliferation assays, tumor growth research, and tissue regeneration studies.
-
Olive Oil Polyphenols and Cardiovascular Protection
2026-09-11
The 2025 reference study compares standard and high-phenolic extra virgin olive oil extracts with hydroxytyrosol and tyrosol across oxidative stress, macrophage inflammation, and cholesterol-efflux assays. Its central contribution is showing that polyphenol concentration and chemical composition influence distinct cardioprotective readouts, while also providing a practical framework for mechanism-focused cardiovascular health research.
-
α-Linolenic Acid: Mechanisms and Research Use
2026-09-10
α-Linolenic Acid (ALA; SKU C3934) is a plant-derived essential omega-3 polyunsaturated fatty acid used in lipid, cardiovascular, inflammation, and cancer biology research. Its documented research value combines defined physicochemical properties with precursor activity for longer-chain omega-3 fatty acids, while assay-specific mechanisms require appropriate controls.
-
ABT-199 (Venetoclax) Workflow for Apoptosis Research
2026-09-10
Build mechanism-focused apoptosis assays with ABT-199 (Venetoclax), a highly selective BCL-2 inhibitor suited to hematologic models and rational combination studies. This guide connects practical compound handling with the reference study’s ATP2B4-centered strategy for testing BCL-2 dependence beyond blood cancers.
-
CD44 Rewiring in IDH-Mutant Leukemia
2026-09-09
The reference study identifies CD44-mediated metabolic rewiring as a dependency of IDH-mutant leukemia, linking pentose phosphate pathway activity and NADPH production to sustained R-2HG synthesis. Its isogenic genetic models and combination-perturbation experiments suggest that pairing mutant IDH inhibition with CD44 blockade may address a metabolic basis of resistance.
-
Native Protein Gel Electrophoresis with K4142
2026-09-09
Discover how native protein gel electrophoresis can preserve charge, conformation, and complex formation while providing a rigorous workflow for acidic proteins. This guide connects K4142 assay design with mechanistic insights from VHL-deficient renal cancer research.
-
Bardoxolone Methyl: Nrf2 & NF-κB
2026-09-08
Bardoxolone methyl, also called CDDO methyl ester, is a synthetic oleanane triterpenoid used to study Nrf2 signaling pathway modulation and NF-kB signaling pathway inhibition. Preclinical findings support oxidative stress research in kidney, leukemia, and lung cancer models, while phase 3 CKD experience highlights important cardiovascular safety limitations.
-
JSH-23: A Practical NF-κB Inhibitor Workflow
2026-09-08
JSH-23 helps separate NF-κB p65 nuclear transcriptional activity from upstream IκB degradation, making it useful for mechanistic inflammation research and cytokine studies. This workflow connects macrophage assays with evidence from a pseudorabies virus model while clearly distinguishing validated applications from translational experiments.
-
InstaBlue Protein Stain Solution for Antibody Studies
2026-09-07
InstaBlue Protein Stain Solution accelerates antibody-development workflows by visualizing protein bands in about 5 minutes without fixation, washing, or destaining. Its low-background, methanol- and acetic acid-free formulation supports gel-based quality control, band excision, and mass spectrometry-oriented analysis.
-
Honokiol Workflows for Cancer Drug Response Assays
2026-09-05
Honokiol can be deployed as an NF-κB pathway inhibitor, reactive oxygen species scavenger, and cancer research probe when viability, cell death, and pathway readouts are separated. This workflow translates those activities into practical dose-response, inflammation, oxidative-stress, and antiangiogenic assay designs.
-
Intravesical p21 mRNA-LNP for Bladder Cancer
2026-09-05
This 2026 FASEB Journal study develops lipid nanoparticles carrying chemically modified p21 mRNA for localized bladder cancer treatment. The work links intravesical delivery with tumor-suppressor restoration, cell-cycle inhibition, DNA-damage signaling, and limited systemic exposure, while also defining important preclinical limitations.
-
BAPTA for Calcium Signaling and Apoptosis
2026-09-04
Use BAPTA as a mechanistic calcium chelator to test whether intracellular Ca2+ elevation is a driver of toxicant-induced apoptosis. This workflow translates an IP3R/Ca2+/STAT3 study into practical controls for intestinal cell models, calcium signaling modulation, and broader cell signaling studies.
-
Fluorouracil Workflows for Solid-Tumor Research
2026-09-04
Build more informative Fluorouracil experiments by pairing thymidylate synthase engagement with viability, replication-stress, and pathway-level readouts. This workflow uses validated colon-tumor benchmarks while extending assay design to cancer-stem-cell biology, including TAK1–YAP regulation in gastric models.
-
ABT-199 Workflow for Mitochondrial Apoptosis
2026-09-03
ABT-199 (Venetoclax) provides a selective way to test whether BCL-2 dependence is driving survival in lymphoma and leukemia models. This practical guide connects dose–response testing, apoptosis readouts, BH3 profiling, and resistance analysis while clarifying how findings from diffuse mesothelioma research should—and should not—be translated.
-
Exercise Capacity Falls Before Muscle Dysfunction
2026-09-03
Zhang et al. show that exercise intolerance develops before measurable intrinsic skeletal muscle dysfunction in experimental pulmonary hypertension. By comparing rat strains with different disease severity, the study separates cardiopulmonary limitations from later muscle atrophy and provides a useful framework for interpreting VO2 max changes in pulmonary hypertension models.